Genisense IVS: Financial statements 2019
CVR: 38157426
Source: annual report 2019, Danish Business Authority
01/09/2018 – 31/08/2019
Genisense IVS (CVR 38157426) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,863 and a net result of DKK -3,012 compared with DKK -3,074 the year before. Equity in the 2019 report amounted to DKK -8,683.
- Gross Profit
- DKK -3,863
- Profit/Loss
- DKK -3,012
- Equity
- DKK -8,683
- Total Assets
- DKK 2,987
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -4 t. | -3 t. | -9 t. | - |
| 2018 | - | -4 t. | -3 t. | -6 t. | - |
| 2017 | - | -4 t. | -4 t. | -3 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Genisense IVS has published its annual report for 2018. Gross profit came to DKK -3,863, and the net result was DKK -3,074.
About Genisense IVS
Genisense IVS was a Danish company of the type Iværksætterselskab based in Silkeborg, founded in 2016. The company has been dissolved on 16 April 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. In 2019, the company reported a gross profit of DKK -3,863 and a net result of DKK -3,012 compared with DKK -3,074 the year before. Equity in the 2019 report amounted to DKK -8,683.